IP Group gives investors access to a portfolio of cutting-edge UK businesses in HealthTech, DeepTech and CleanTech that would otherwise be difficult for most private investors to reach. Despite a mature portfolio, strong cash generation, and exposure to breakthrough technologies emerging from leading UK universities, IP Group's shares trade at a 43% discount to NAV, which appears excessive given that most exits have been at a premium to NAV. ▶️ Watch now for our latest investment view on IP Group and the potential upside from narrowing the discount to asset value. Read our initiation research note in full here: https://www.equitydevelopment.co.uk/research/focused-venture-investor-with-wave-of-exits-ahead #IPGroup #IPG #Investing #UKStocks #SmallCaps #VentureCapital #HealthTech #DeepTech #CleanTech #EquityDevelopment